BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 15699258)

  • 1. Risk of restenosis and health status outcomes for patients undergoing percutaneous coronary intervention versus coronary artery bypass graft surgery.
    Spertus JA; Nerella R; Kettlekamp R; House J; Marso S; Borkon AM; Rumsfeld JS
    Circulation; 2005 Feb; 111(6):768-73. PubMed ID: 15699258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of age on outcomes after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: one-year results from the Stent or Surgery (SoS) trial.
    Zhang Z; Mahoney EM; Spertus JA; Booth J; Nugara F; Kolm P; Stables RH; Weintraub WS
    Am Heart J; 2006 Dec; 152(6):1153-60. PubMed ID: 17161069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease-specific health status after stent-assisted percutaneous coronary intervention and coronary artery bypass surgery: one-year results from the Stent or Surgery trial.
    Zhang Z; Mahoney EM; Stables RH; Booth J; Nugara F; Spertus JA; Weintraub WS
    Circulation; 2003 Oct; 108(14):1694-700. PubMed ID: 12975252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using the risk of restenosis as a guide to triaging patients between surgical and percutaneous coronary revascularization.
    Kettelkamp R; House J; Garg M; Stuart RS; Grantham A; Spertus J
    Circulation; 2004 Sep; 110(11 Suppl 1):II50-4. PubMed ID: 15364838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative benefit of coronary artery bypass grafting versus stent-assisted percutaneous coronary intervention for angina pectoris and multivessel coronary disease in women versus men (one-year results from the Stent or Surgery trial).
    Zhang Z; Weintraub WS; Mahoney EM; Spertus JA; Booth J; Nugara F; Stables RH; Vaccarino V
    Am J Cardiol; 2004 Feb; 93(4):404-9. PubMed ID: 14969611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management.
    Norris CM; Saunders LD; Ghali WA; Brant R; Galbraith PD; Graham M; Faris P; Dzavik V; Knudtson ML;
    Can J Cardiol; 2004 Oct; 20(12):1259-66. PubMed ID: 15494780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention with drug-eluting stents for patients with multivessel coronary artery disease.
    Javaid A; Steinberg DH; Buch AN; Corso PJ; Boyce SW; Pinto Slottow TL; Roy PK; Hill P; Okabe T; Torguson R; Smith KA; Xue Z; Gevorkian N; Suddath WO; Kent KM; Satler LF; Pichard AD; Waksman R
    Circulation; 2007 Sep; 116(11 Suppl):I200-6. PubMed ID: 17846304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current clinical outcomes of percutaneous coronary intervention and coronary artery bypass grafting.
    Mack MJ; Prince SL; Herbert M; Brown PP; Katz M; Palmer G; Edgerton JR; Eichhorn E; Magee MJ; Dewey TM
    Ann Thorac Surg; 2008 Aug; 86(2):496-503; discussion 503. PubMed ID: 18640323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease.
    Lee MS; Kapoor N; Jamal F; Czer L; Aragon J; Forrester J; Kar S; Dohad S; Kass R; Eigler N; Trento A; Shah PK; Makkar RR
    J Am Coll Cardiol; 2006 Feb; 47(4):864-70. PubMed ID: 16487857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of coronary-artery bypass graft surgery versus percutaneous coronary intervention for multivessel coronary artery disease in the bare-metal stent era.
    Kimura T; Morimoto T; Furukawa Y; Nakagawa Y; Shizuta S; Ehara N; Taniguchi R; Doi T; Nishiyama K; Ozasa N; Saito N; Hoshino K; Mitsuoka H; Abe M; Toma M; Tamura T; Haruna Y; Imai Y; Teramukai S; Fukushima M; Kita T
    Circulation; 2008 Sep; 118(14 Suppl):S199-209. PubMed ID: 18824755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
    Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of multiple previous percutaneous coronary interventions in patients undergoing elective coronary artery bypass surgery.
    Thielmann M; Leyh R; Massoudy P; Neuhäuser M; Aleksic I; Kamler M; Herold U; Piotrowski J; Jakob H
    Circulation; 2006 Jul; 114(1 Suppl):I441-7. PubMed ID: 16820616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease.
    Yang ZK; Shen WF; Zhang RY; Kong Y; Zhang JS; Hu J; Zhang Q; Ding FH
    J Interv Cardiol; 2007 Feb; 20(1):10-6. PubMed ID: 17300391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for impaired health status differ in women and men treated with percutaneous coronary intervention in the drug-eluting stent era.
    Pedersen SS; Ong AT; Lemos PA; Erdman RA; Serruys PW; van Domburg RT
    J Psychosom Res; 2006 Jul; 61(1):11-7. PubMed ID: 16813840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of quality of life after repeat versus initial coronary artery bypass grafting.
    Safley DM; House JA; Borkon AM; Spertus JA
    Am J Cardiol; 2004 Aug; 94(4):494-7. PubMed ID: 15325938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary artery bypass surgery versus percutaneous coronary artery intervention in patients on chronic hemodialysis: does a drug-eluting stent have an impact on clinical outcome?
    Manabe S; Shimokawa T; Fukui T; Fumimoto KU; Ozawa N; Seki H; Takanashi S
    J Card Surg; 2009; 24(3):234-9. PubMed ID: 19438773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of quality-of-life benefit after percutaneous coronary intervention.
    Spertus JA; Salisbury AC; Jones PG; Conaway DG; Thompson RC
    Circulation; 2004 Dec; 110(25):3789-94. PubMed ID: 15596563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.
    Halkin A; Selzer F; Marroquin O; Laskey W; Detre K; Cohen H
    J Invasive Cardiol; 2006 Dec; 18(12):577-83. PubMed ID: 17197706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.